---
pmid: '23122816'
title: Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase
  I inhibitors.
authors:
- Chiba T
- Ohwada J
- Sakamoto H
- Kobayashi T
- Fukami TA
- Irie M
- Miura T
- Ohara K
- Koyano H
journal: Bioorg Med Chem Lett
year: '2012'
full_text_available: false
doi: 10.1016/j.bmcl.2012.10.045
---

# Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors.
**Authors:** Chiba T, Ohwada J, Sakamoto H, Kobayashi T, Fukami TA, Irie M, Miura T, Ohara K, Koyano H
**Journal:** Bioorg Med Chem Lett (2012)
**DOI:** [10.1016/j.bmcl.2012.10.045](https://doi.org/10.1016/j.bmcl.2012.10.045)

## Abstract

1. Bioorg Med Chem Lett. 2012 Dec 15;22(24):7486-9. doi: 
10.1016/j.bmcl.2012.10.045. Epub 2012 Oct 17.

Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase 
I inhibitors.

Chiba T(1), Ohwada J, Sakamoto H, Kobayashi T, Fukami TA, Irie M, Miura T, Ohara 
K, Koyano H.

Author information:
(1)Research Division, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara Kamakura, 
Kanagawa 247-8530, Japan.

We conducted a high throughput screening for glyoxalase I (GLO1) inhibitors and 
identified 4,6-diphenyl-N-hydroxypyridone as a lead compound. Using a binding 
model of the lead and public X-ray coordinates of GLO1 enzymes complexed with 
glutathione analogues, we designed 4-(7-azaindole)-substituted 
6-phenyl-N-hydroxypyridones. 7-Azaindole's 7-nitrogen was expected to interact 
with a water network, resulting in an interaction with the protein. We validated 
this inhibitor design by comparing its structure-activity relationship (SAR) 
with that of corresponding indole derivatives, by analyzing the binding mode 
with X-ray crystallography and by evaluating its thermodynamic binding 
parameters.

Copyright Â© 2012 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.bmcl.2012.10.045
PMID: 23122816 [Indexed for MEDLINE]
